drugset / Trial / NCT00925028

Warfarin Patient Self-Monitoring

NCT00925028 ↗

Completed 25 enrolled University of British Columbia
RandomizedCrossoverOpen-labelTreatment

Summary

Atrial Fibrillation is a heart condition in which people are treated with blood thinners such as warfarin to decrease the risk of stroke. Large studies have shown that when patients adjust their own dose of warfarin, similar to insulin, results are better. The purpose of this study is to evaluate whether implementing this method of warfarin management is beneficial in a Canadian primary care clinic. Patients will be educated on how to adjust their own warfarin doses when necessary using simple charts. The success of patient self management will be compared against management by a physician.

Timeline

Start
2009-07
Primary completion
2010-03
Completion
2010-03

Outcome

Missed primary endpoint

paper The mean proportion of INR values in therapeutic range among subjects in the PSM and physician-management groups was 82% and 80%, respectively (P = .82). PMID 21841092 ↗

paper Patient self-management was not demonstrated to be superior to standard care PMID 21841092 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Warfarin Small molecule 1 mg —
Subject Warfarin Small molecule 5 mg —

Indications